aluates Reports

$ 0.0

Automative

Global Oral Solid Dosage Medicine Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-17L12820

Global Oral Solid Dosage Medicine Market Research Report 2022

BUY CHAPTERS

Global Oral Solid Dosage Medicine Market Research Report 2025

Code: QYRE-Auto-17L12820

Report

February 2025

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Novartis

Roche

AbbVie

Merck

Bristol–Myers Squibb

GlaxoSmithKline PLC

Pfizer Inc

Sanofi

Takeda

Astrazeneca plc

Bayer

Eli Lilly & Co

Gilead Sciences

Amgen Inc

Novo Nordisk

TEVA

Boehringer Ingelheim

Biogen

Astellas

Oral Solid Dosage Medicine Market Size

The global market for Oral Solid Dosage Medicine was valued at US$ 392040 million in the year 2024 and is projected to reach a revised size of US$ 549010 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Oral Solid Dosage Medicine Market

Oral drug delivery is the most convenient, high patient compliant, cost effective, and safe route of administration to treat various diseases. Oral solid dosage (OSD) form refers to a final drug product that is ingested through the mouth, dissolved in the digestive system, and delivered to the body through absorption into the bloodstream. The most common OSD forms - tablets and capsules - are efficient and cost-effective to manufacture, shelf stable and easy to administer. They are widely understood and embraced by patients worldwide. They are preferred by pharmaceutical manufacturers owing to the advantage of economy of scale.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Medicine.

The Oral Solid Dosage Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Solid Dosage Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Solid Dosage Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Solid Dosage Medicine Market Report

Report Metric	Details
Report Name	Oral Solid Dosage Medicine Market
Accounted market size in year	US$ 392040 million
Forecasted market size in 2031	US$ 549010 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Brands Drugs Generic Drugs
Segment by Application	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Solid Dosage Medicine Market growing?

Ans: The Oral Solid Dosage Medicine Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Oral Solid Dosage Medicine Market size in 2031?

Ans: The Oral Solid Dosage Medicine Market size in 2031 will be US$ 549010 million.

Who are the main players in the Oral Solid Dosage Medicine Market report?

Ans: The main players in the Oral Solid Dosage Medicine Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas

What are the Application segmentation covered in the Oral Solid Dosage Medicine Market report?

Ans: The Applications covered in the Oral Solid Dosage Medicine Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the Oral Solid Dosage Medicine Market report?

Ans: The Types covered in the Oral Solid Dosage Medicine Market report are Brands Drugs, Generic Drugs

Recommended Reports

Oral Dosage Pharmaceuticals

Oral Disease Treatments

Pharma Packaging & Excipients

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Solid Dosage Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Brands Drugs

1.2.3 Generic Drugs

1.3 Market by Application

1.3.1 Global Oral Solid Dosage Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Solid Dosage Medicine Market Perspective (2020-2031)

2.2 Global Oral Solid Dosage Medicine Growth Trends by Region

2.2.1 Global Oral Solid Dosage Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Solid Dosage Medicine Historic Market Size by Region (2020-2025)

2.2.3 Oral Solid Dosage Medicine Forecasted Market Size by Region (2026-2031)

2.3 Oral Solid Dosage Medicine Market Dynamics

2.3.1 Oral Solid Dosage Medicine Industry Trends

2.3.2 Oral Solid Dosage Medicine Market Drivers

2.3.3 Oral Solid Dosage Medicine Market Challenges

2.3.4 Oral Solid Dosage Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Solid Dosage Medicine Players by Revenue

3.1.1 Global Top Oral Solid Dosage Medicine Players by Revenue (2020-2025)

3.1.2 Global Oral Solid Dosage Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Oral Solid Dosage Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Solid Dosage Medicine Revenue

3.4 Global Oral Solid Dosage Medicine Market Concentration Ratio

3.4.1 Global Oral Solid Dosage Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Medicine Revenue in 2024

3.5 Global Key Players of Oral Solid Dosage Medicine Head office and Area Served

3.6 Global Key Players of Oral Solid Dosage Medicine, Product and Application

3.7 Global Key Players of Oral Solid Dosage Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Medicine Breakdown Data by Type

4.1 Global Oral Solid Dosage Medicine Historic Market Size by Type (2020-2025)

4.2 Global Oral Solid Dosage Medicine Forecasted Market Size by Type (2026-2031)

5 Oral Solid Dosage Medicine Breakdown Data by Application

5.1 Global Oral Solid Dosage Medicine Historic Market Size by Application (2020-2025)

5.2 Global Oral Solid Dosage Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Solid Dosage Medicine Market Size (2020-2031)

6.2 North America Oral Solid Dosage Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Solid Dosage Medicine Market Size by Country (2020-2025)

6.4 North America Oral Solid Dosage Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Solid Dosage Medicine Market Size (2020-2031)

7.2 Europe Oral Solid Dosage Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Solid Dosage Medicine Market Size by Country (2020-2025)

7.4 Europe Oral Solid Dosage Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Solid Dosage Medicine Market Size (2020-2031)

8.2 Asia-Pacific Oral Solid Dosage Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Solid Dosage Medicine Market Size (2020-2031)

9.2 Latin America Oral Solid Dosage Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Solid Dosage Medicine Market Size by Country (2020-2025)

9.4 Latin America Oral Solid Dosage Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Solid Dosage Medicine Market Size (2020-2031)

10.2 Middle East & Africa Oral Solid Dosage Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Oral Solid Dosage Medicine Introduction

11.1.4 Johnson & Johnson Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.1.5 Johnson & Johnson Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Oral Solid Dosage Medicine Introduction

11.2.4 Novartis Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Oral Solid Dosage Medicine Introduction

11.3.4 Roche Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.3.5 Roche Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Oral Solid Dosage Medicine Introduction

11.4.4 AbbVie Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.4.5 AbbVie Recent Development

11.5 Merck & Co.

11.5.1 Merck & Co. Company Details

11.5.2 Merck & Co. Business Overview

11.5.3 Merck & Co. Oral Solid Dosage Medicine Introduction

11.5.4 Merck & Co. Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.5.5 Merck & Co. Recent Development

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Details

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Oral Solid Dosage Medicine Introduction

11.6.4 Bristol Myers Squibb Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.6.5 Bristol Myers Squibb Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Oral Solid Dosage Medicine Introduction

11.7.4 GlaxoSmithKline Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.7.5 GlaxoSmithKline Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Oral Solid Dosage Medicine Introduction

11.8.4 Pfizer Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.8.5 Pfizer Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Oral Solid Dosage Medicine Introduction

11.9.4 Sanofi Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.9.5 Sanofi Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Oral Solid Dosage Medicine Introduction

11.10.4 Takeda Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Details

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Oral Solid Dosage Medicine Introduction

11.11.4 AstraZeneca Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.11.5 AstraZeneca Recent Development

11.12 Bayer

11.12.1 Bayer Company Details

11.12.2 Bayer Business Overview

11.12.3 Bayer Oral Solid Dosage Medicine Introduction

11.12.4 Bayer Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.12.5 Bayer Recent Development

11.13 Eli Lilly & Co.

11.13.1 Eli Lilly & Co. Company Details

11.13.2 Eli Lilly & Co. Business Overview

11.13.3 Eli Lilly & Co. Oral Solid Dosage Medicine Introduction

11.13.4 Eli Lilly & Co. Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.13.5 Eli Lilly & Co. Recent Development

11.14 Gilead Sciences

11.14.1 Gilead Sciences Company Details

11.14.2 Gilead Sciences Business Overview

11.14.3 Gilead Sciences Oral Solid Dosage Medicine Introduction

11.14.4 Gilead Sciences Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.14.5 Gilead Sciences Recent Development

11.15 Amgen

11.15.1 Amgen Company Details

11.15.2 Amgen Business Overview

11.15.3 Amgen Oral Solid Dosage Medicine Introduction

11.15.4 Amgen Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.15.5 Amgen Recent Development

11.16 Novo Nordisk

11.16.1 Novo Nordisk Company Details

11.16.2 Novo Nordisk Business Overview

11.16.3 Novo Nordisk Oral Solid Dosage Medicine Introduction

11.16.4 Novo Nordisk Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.16.5 Novo Nordisk Recent Development

11.17 Teva

11.17.1 Teva Company Details

11.17.2 Teva Business Overview

11.17.3 Teva Oral Solid Dosage Medicine Introduction

11.17.4 Teva Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.17.5 Teva Recent Development

11.18 Boehringer Ingelheim

11.18.1 Boehringer Ingelheim Company Details

11.18.2 Boehringer Ingelheim Business Overview

11.18.3 Boehringer Ingelheim Oral Solid Dosage Medicine Introduction

11.18.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.18.5 Boehringer Ingelheim Recent Development

11.19 Biogen

11.19.1 Biogen Company Details

11.19.2 Biogen Business Overview

11.19.3 Biogen Oral Solid Dosage Medicine Introduction

11.19.4 Biogen Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.19.5 Biogen Recent Development

11.20 Astellas

11.20.1 Astellas Company Details

11.20.2 Astellas Business Overview

11.20.3 Astellas Oral Solid Dosage Medicine Introduction

11.20.4 Astellas Revenue in Oral Solid Dosage Medicine Business (2020-2025)

11.20.5 Astellas Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Novartis

Roche

AbbVie

Merck

Bristol–Myers Squibb

GlaxoSmithKline PLC

Pfizer Inc

Sanofi

Takeda

Astrazeneca plc

Bayer

Eli Lilly & Co

Gilead Sciences

Amgen Inc

Novo Nordisk

TEVA

Boehringer Ingelheim

Biogen

Astellas

List of Tables

Table 1. Global Oral Solid Dosage Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Brands Drugs

Table 3. Key Players of Generic Drugs

Table 4. Global Oral Solid Dosage Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Oral Solid Dosage Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oral Solid Dosage Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Oral Solid Dosage Medicine Market Share by Region (2020-2025)

Table 8. Global Oral Solid Dosage Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Oral Solid Dosage Medicine Market Share by Region (2026-2031)

Table 10. Oral Solid Dosage Medicine Market Trends

Table 11. Oral Solid Dosage Medicine Market Drivers

Table 12. Oral Solid Dosage Medicine Market Challenges

Table 13. Oral Solid Dosage Medicine Market Restraints

Table 14. Global Oral Solid Dosage Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Oral Solid Dosage Medicine Market Share by Players (2020-2025)

Table 16. Global Top Oral Solid Dosage Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Medicine as of 2024)

Table 17. Ranking of Global Top Oral Solid Dosage Medicine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Oral Solid Dosage Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Oral Solid Dosage Medicine, Headquarters and Area Served

Table 20. Global Key Players of Oral Solid Dosage Medicine, Product and Application

Table 21. Global Key Players of Oral Solid Dosage Medicine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Oral Solid Dosage Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Oral Solid Dosage Medicine Revenue Market Share by Type (2020-2025)

Table 25. Global Oral Solid Dosage Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Oral Solid Dosage Medicine Revenue Market Share by Type (2026-2031)

Table 27. Global Oral Solid Dosage Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Oral Solid Dosage Medicine Revenue Market Share by Application (2020-2025)

Table 29. Global Oral Solid Dosage Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Oral Solid Dosage Medicine Revenue Market Share by Application (2026-2031)

Table 31. North America Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Oral Solid Dosage Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Oral Solid Dosage Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Oral Solid Dosage Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Oral Solid Dosage Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Oral Solid Dosage Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Oral Solid Dosage Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Oral Solid Dosage Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 46. Johnson & Johnson Company Details

Table 47. Johnson & Johnson Business Overview

Table 48. Johnson & Johnson Oral Solid Dosage Medicine Product

Table 49. Johnson & Johnson Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 50. Johnson & Johnson Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Oral Solid Dosage Medicine Product

Table 54. Novartis Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Oral Solid Dosage Medicine Product

Table 59. Roche Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. AbbVie Company Details

Table 62. AbbVie Business Overview

Table 63. AbbVie Oral Solid Dosage Medicine Product

Table 64. AbbVie Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 65. AbbVie Recent Development

Table 66. Merck & Co. Company Details

Table 67. Merck & Co. Business Overview

Table 68. Merck & Co. Oral Solid Dosage Medicine Product

Table 69. Merck & Co. Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 70. Merck & Co. Recent Development

Table 71. Bristol Myers Squibb Company Details

Table 72. Bristol Myers Squibb Business Overview

Table 73. Bristol Myers Squibb Oral Solid Dosage Medicine Product

Table 74. Bristol Myers Squibb Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 75. Bristol Myers Squibb Recent Development

Table 76. GlaxoSmithKline Company Details

Table 77. GlaxoSmithKline Business Overview

Table 78. GlaxoSmithKline Oral Solid Dosage Medicine Product

Table 79. GlaxoSmithKline Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 80. GlaxoSmithKline Recent Development

Table 81. Pfizer Company Details

Table 82. Pfizer Business Overview

Table 83. Pfizer Oral Solid Dosage Medicine Product

Table 84. Pfizer Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 85. Pfizer Recent Development

Table 86. Sanofi Company Details

Table 87. Sanofi Business Overview

Table 88. Sanofi Oral Solid Dosage Medicine Product

Table 89. Sanofi Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 90. Sanofi Recent Development

Table 91. Takeda Company Details

Table 92. Takeda Business Overview

Table 93. Takeda Oral Solid Dosage Medicine Product

Table 94. Takeda Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 95. Takeda Recent Development

Table 96. AstraZeneca Company Details

Table 97. AstraZeneca Business Overview

Table 98. AstraZeneca Oral Solid Dosage Medicine Product

Table 99. AstraZeneca Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 100. AstraZeneca Recent Development

Table 101. Bayer Company Details

Table 102. Bayer Business Overview

Table 103. Bayer Oral Solid Dosage Medicine Product

Table 104. Bayer Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 105. Bayer Recent Development

Table 106. Eli Lilly & Co. Company Details

Table 107. Eli Lilly & Co. Business Overview

Table 108. Eli Lilly & Co. Oral Solid Dosage Medicine Product

Table 109. Eli Lilly & Co. Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 110. Eli Lilly & Co. Recent Development

Table 111. Gilead Sciences Company Details

Table 112. Gilead Sciences Business Overview

Table 113. Gilead Sciences Oral Solid Dosage Medicine Product

Table 114. Gilead Sciences Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 115. Gilead Sciences Recent Development

Table 116. Amgen Company Details

Table 117. Amgen Business Overview

Table 118. Amgen Oral Solid Dosage Medicine Product

Table 119. Amgen Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 120. Amgen Recent Development

Table 121. Novo Nordisk Company Details

Table 122. Novo Nordisk Business Overview

Table 123. Novo Nordisk Oral Solid Dosage Medicine Product

Table 124. Novo Nordisk Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 125. Novo Nordisk Recent Development

Table 126. Teva Company Details

Table 127. Teva Business Overview

Table 128. Teva Oral Solid Dosage Medicine Product

Table 129. Teva Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 130. Teva Recent Development

Table 131. Boehringer Ingelheim Company Details

Table 132. Boehringer Ingelheim Business Overview

Table 133. Boehringer Ingelheim Oral Solid Dosage Medicine Product

Table 134. Boehringer Ingelheim Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 135. Boehringer Ingelheim Recent Development

Table 136. Biogen Company Details

Table 137. Biogen Business Overview

Table 138. Biogen Oral Solid Dosage Medicine Product

Table 139. Biogen Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 140. Biogen Recent Development

Table 141. Astellas Company Details

Table 142. Astellas Business Overview

Table 143. Astellas Oral Solid Dosage Medicine Product

Table 144. Astellas Revenue in Oral Solid Dosage Medicine Business (2020-2025) & (US$ Million)

Table 145. Astellas Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Oral Solid Dosage Medicine Picture

Figure 2. Global Oral Solid Dosage Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Solid Dosage Medicine Market Share by Type: 2024 VS 2031

Figure 4. Brands Drugs Features

Figure 5. Generic Drugs Features

Figure 6. Global Oral Solid Dosage Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Oral Solid Dosage Medicine Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Oral Solid Dosage Medicine Report Years Considered

Figure 11. Global Oral Solid Dosage Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Oral Solid Dosage Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Oral Solid Dosage Medicine Market Share by Region: 2024 VS 2031

Figure 14. Global Oral Solid Dosage Medicine Market Share by Players in 2024

Figure 15. Global Top Oral Solid Dosage Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Medicine as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Oral Solid Dosage Medicine Revenue in 2024

Figure 17. North America Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Oral Solid Dosage Medicine Market Share by Country (2020-2031)

Figure 19. United States Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Oral Solid Dosage Medicine Market Share by Country (2020-2031)

Figure 23. Germany Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Oral Solid Dosage Medicine Market Share by Region (2020-2031)

Figure 31. China Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Oral Solid Dosage Medicine Market Share by Country (2020-2031)

Figure 39. Mexico Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Oral Solid Dosage Medicine Market Share by Country (2020-2031)

Figure 43. Turkey Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Oral Solid Dosage Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Johnson & Johnson Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 47. Novartis Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 48. Roche Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 49. AbbVie Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 50. Merck & Co. Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 51. Bristol Myers Squibb Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 55. Takeda Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 56. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 58. Eli Lilly & Co. Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 59. Gilead Sciences Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 60. Amgen Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 61. Novo Nordisk Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 62. Teva Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 63. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 64. Biogen Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 65. Astellas Revenue Growth Rate in Oral Solid Dosage Medicine Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2024

Global Oral Solid Dose Market Research Report 2024

Solid Dosage Form Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Solid Dosage Manufacturing Market Research Report 2025

Solid Preparation Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Orodispersible Tablets Market Insights Forecast to 2030

Global Oral Thin Film OTF Drug Delivery Systems Market Research Report 2024

Global Oral Mucosal Drug Delivery System Market Research Report 2024

Global Oral Disintegrating Strips Market Research Report 2024

Global Orally Disintegrating Tablets Market Research Report 2024

Orally Disintegrating Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mouth dissolving Tablets Market Insights Forecast to 2030

Oral Dose Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Solid Dosage Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Orally Disintegrating Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024

Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030

Global Orally Disintegrating Tablet Technology Market Research Report 2024

Global Oral Thin film Drug Delivery Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions